Artificial intelligence in biopharma Germany - Canadian Technology Accelerator

Application deadline - July 15 at 11:59 pm Pacific Time

Are you ready to grow your AI-in-(bio)pharma solution to Europe’s largest healthcare market? 
This premier initiative empowers Canadian companies that offer AI-empowered technologies in the following sectors to successfully expand their operations into Germany:

• precision/personalized medicine

• cell & gene therapy

• drug discovery

• orphan drugs

This program offers a unique opportunity for innovative Canadian enterprises to tap into the thriving German market, renowned for its:

• robust healthcare infrastructure

• cutting-edge research facilities

• strong commitment to medical advancements

Join the information webinar on Thursday, July 10 at 11:00am ET to learn more about what participants can expect from the program and from what they will benefit during the in-market week in Germany. Interested companies can register for this webinar here.